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 ORIGINAL INVESTIGATION 
 Chronotherapeutics and psychiatry: Setting the clock to relieve 
the symptoms
 ANDREW N.  COOGAN 1  &  JOHANNES  THOME 2 
 1 Department of Psychology, National University of Ireland, Maynooth, Republic of Ireland ,  2 Department of Psychiatry, 
University of Rostock, Rostock, Germany 
 Abstract 
 Circadian rhythms are near 24-h cycles in a number of physiological and behavioural parameters and the underpinning 
circadian timing systems is one of the key homeostatic regulatory systems in mammalian physiology. Many common 
psychiatric conditions are associated with disrupted sleep, including a common occurrence of delayed or advanced phase 
sleep syndromes, which in themselves may be indicative of dysregulated circadian timing in these disorders. In this article 
we discuss the evidence for abnormal circadian rhythms in seasonal affective disorder, bipolar disorder and attention 
defi cit/hyperactivity disorder. Much of this evidence suggest that these conditions are associated with either phase delays 
or phase advances of core phase markers of the circadian clock such as melatonin or core body temperature, suggesting 
the presence of circadian desynchrony in these conditions. We also highlight fi ndings that pharmacological and/or behavioural 
interventions that ameliorate circadian misalignments are effi cacious in producing symptomatic relief, suggesting an intrinsic 
link between the circadian and affective systems that can be manipulated for clinical benefi t. 
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 Introduction 
 Circadian rhythms are recurring near 24-h patterns 
that occur in a host of metabolic, physiological, behav-
ioural and cognitive processes. These rhythms are 
generated by internal circadian timekeeping system 
which serves to impose a temporal architecture on an 
organism ' s physiology (Reppert and Weaver 2002). In 
constant environmental conditions, the internally 
generated circadian rhythm may deviate from 24 h 
exactly (circadian does indeed translate as about a 
day), but in any normal situation that an animal may 
fi nd itself in, it will be exposed to a number of envi-
ronmental time cues, such as sunrise/sunset, food 
availability, social interaction and ambient temperate 
fl uctuations. These environmental factors may act as 
entraining, or synchronising inputs to the circadian 
clock (Zeitgebers) in order to ensure that the inter-
nally generated time is appropriate to environmental 
cycles. For humans, and other animals, the dominant 
Zeitgeber is light, and as the solar cycle is by defi nition 
24 h, then normally the circadian clock is entrained 
to this cycle so as to display a period of exactly 24 h. 
However, there is accumulating evidence that a num-
ber of factors, such as neurological and psychiatric 
disorders, medication, shift work and old age may 
weaken the entrainment of the central clock to envi-
ronmental Zeitgebers, in turn leading to a circadian 
desynchrony between internal and external cycles 
(e.g., Beynon et al. 2009; Wulff et al. 2010; Coogan 
et al. 2011). Such desynchrony may in turn be detri-
mental to psychological and physiological processes. 
In this article I will explore the evidence that such 
circadian dysfunction may occur in psychiatric disor-
ders, and explore the possibilities and applications of 
treatments that restore circadian synchrony being 
used for symptomatic relief in such conditions. 
 Evidence for abnormal circadian 
timekeeping in psychiatric disorders 
 Clock genes are the core molecular components 
that allow for the generation of circadian rhythmicity. 
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 Studies in patients with bipolar disorder also 
report changes in circadian parameters. Jones and 
Evershed (2005) report that euthymic patients 
display weakened stability and increased variability 
of circadian motor behaviour as assessed by actigra-
phy, with circadian variability being found to be 
predictive of diagnostic group. Ankers and Jones 
(2009) further report that individuals at high risk 
of bipolar disorder showed altered circadian patterns 
in motor activity compared to controls prior to ill-
ness onset. Melatonin levels are reported to be sup-
pressed in bipolar disorder, with phase advances of 
the melatonin rhythm associated with mania and 
phase delays with depressive episodes or euthymia 
(Dallaspezia and Benedetti 2009). Yang et al. (2009) 
utilised an  ex vivo approach to examine circadian 
rhythms in clock gene expression profi les in fi bro-
blasts either obtained from bipolar disorder patients 
or healthy controls, and report that  BMAL1, 
PER1, PER2, REV-ERB- α and the clock controlled 
gene  DBP all tended towards reduced amplitudes of 
circadian oscillation in bipolar disorder. Further, 
these authors show that in a sub-group of patient 
samples there is a signifi cant underexpression 
of phosphorylated glycogen synthase kinase-3 β 
 ( GSK-3 β ) . This is a striking fi nding as GSK-3 β is 
a known substrate for the mood stabiliser lithium. 
Further, lithium is known to alter the master circadian 
clock, and its molecular mechanism has recently 
been described as involving GSK-3 β and  rev-erb- α 
(Yin et al. 2006). Thus there appears to be a molecu-
lar pathway for the action of lithium on the core cir-
cadian clock with apparent therapeutic implications. 
 If circadian rhythms are altered in bipolar 
disorder, then might interventions that alter the cir-
cadian clock be effi cacious in symptomatic relief? 
It has long been a clinical observation that sleep 
deprivation is associated with anti-depressant effects, 
although the mechanism underpinning such effects 
have been obscure. One such putative mechanism 
is a phase-resetting effect of sleep deprivation on 
circadian rhythms, which in turn may counter circa-
dian desynchrony that contributes to depression. 
Benedetti et al. (2007) examined the effects of total 
sleep deprivation coupled to light therapy in type I 
bipolar patients. Anti-depressant effects of the sleep 
deprivation/light therapy intervention was correlated 
with increases in daytime activity and phase advances 
in the actigraphically determined diurnal rhythm, 
whilst non-responders did not show changes in 
these parameters. Therefore these authors posit that 
phase advances of the circadian rhythm is a correlate 
of the antidepressant action of sleep deprivation/light 
therapy in a situation that can be seen as being 
similar to that described above in SAD. The role 
of circadian factors in symptom cycling in bipolar 
A number of genetic association studies have linked 
polymorphisms in a number of clock genes with 
a number of psychiatric disorders, such as major 
depression, bipolar disorder, attention-defi cit/
hyperactivity disorder, schizophrenia and seasonal-
affective disorder (Lamont et al. 2007). Such asso-
ciations are of interest, but care must always be 
taken in the interpretation of such results given the 
paucity of data on the infl uences on such polymor-
phisms on protein function and ultimately circadian 
function. 
 More direct evidence comes from the analysis of 
circadian rhythms in psychiatric patients cohorts 
when compared to well-matched healthy controls. 
Often the fi rst signs of disordered circadian function 
become obvious when manifested through sleep 
disturbance, which in turn is a very common hall-
mark of many psychiatric conditions. Circadian 
abnormalities may present themselves as delayed 
or advanced sleep phase syndromes, and such dis-
turbances are reported as being co-morbid with 
major depression, winter depression and ADHD, 
amongst others (Dagan 2002). Delayed or advanced 
sleep phase syndromes may be indicative of underly-
ing phase-misalignment of the circadian system, 
as under the two process model of sleep regulation 
circadian time has a major infl uence on sleep onset 
(Borb é ly 1982). 
 A number of studies have directly assessed the 
functioning of the circadian systems in patients 
with affective and other psychiatric disorders, using 
a variety of endocrine, behavioural and molecular 
approaches. For example, in a seminal study by 
Lewy et al. (2006) it was reported that seasonal 
affective disorder (SAD) is associated with a phase-
delay in the dim light melatonin onset (DLMO: 
one of the gold standards for phase-markers of 
the circadian rhythm) in about two-thirds of patients 
with SAD with the remaining one-third of patients 
demonstrating a phase advance of the DLMO. These 
data indicate that SAD is associated with a misalign-
ment of the circadian clock to the shortening of 
the photoperiod and delayed light onset during win-
ter. This circadian desynchrony may in turn help 
explain some of the atypical neurovegative symptoms 
that also occur in SAD, such as hyperphagia and 
consequent weight gain, as the circadian system 
plays roles in not only in the affective system, but 
also in other key homeostatic systems such as energy 
balance and feeding regulation. Further evidence 
for the role of circadian misalignment in SAD 
comes from the fi ndings that application of bright 
light therapy and melatonin treatment, at the appro-
priate time to counter either the phase delays or 
advances of the DLMO, alleviates the depression 
(Lewy et al. 2006). 
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through the serotoninergic system, and through 
the interplay of circadian and non-circadian effects. 
Resolution of these issues will cast much new light 
on the circadian involvement in mood disorders 
and lay the ground for the development of novel 
behavioural and pharmacological treatment. 
 Conclusion 
 There are consistent indications in the literature 
for the perturbation of circadian rhythms in numer-
ous psychiatric disorders. Congruent with this, 
treatments that alter circadian phase and possibly 
ameliorate illness-related circadian dysfunction 
appear to be effective in symptom relief. Further 
study is needed to understand the causality of the 
circadian-psychiatric disorder relationship and to 
better understand how behavioural and pharmaceu-
tical interventions can be best applied in the clinic. 
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